![David Christopher Hayward](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Christopher Hayward
Chief Executive Officer at Micropore Technologies Ltd.
Profile
David Christopher Hayward is currently the Chief Executive Officer of Micropore Technologies Ltd.
He previously held the position of Chief Executive Officer at CellAura Technologies Ltd.
and Chief Executive Officer & Director at Q-Flo Ltd.
David Christopher Hayward active positions
Companies | Position | Start |
---|---|---|
Micropore Technologies Ltd.
![]() Micropore Technologies Ltd. BiotechnologyHealth Technology Micropore Technologies Ltd. develops and manufactures membrane emulsification technologies and chemicals. The firm offers entry level dispersion cells, laboratory scale torsional systems, laboratory scale crossflow systems, pilot and production scale torsional systems, and pilot and production scale crossflow systems; and consultancy services. Its products are used in pharmaceuticals, food and beverages, chromatography, inks, nutraceuticals, specialist particles and emulsions, agrochemical, veterinarian and animal feed, and insect repellents, as well as cosmetics, fragrances, and skincare applications. The company was founded by Richard Holdich in 2003 and is headquartered in Redcar, the United Kingdom. | Chief Executive Officer | 2009-12-31 |
Former positions of David Christopher Hayward
Companies | Position | End |
---|---|---|
Q-Flo Ltd.
![]() Q-Flo Ltd. Miscellaneous Commercial ServicesCommercial Services Q-Flo Ltd. provides research in the areas of advanced nano-enabled materials. It produces long carbon nanotube fibre and mats is patent protected and operates as a single stage continuous process. The company was founded by Alan Windle and Martin Pick in 2004 and is headquartered in Nottingham, the United Kingdom. | Chief Executive Officer | - |
CellAura Technologies Ltd.
![]() CellAura Technologies Ltd. Pharmaceuticals: MajorHealth Technology CellAura Technologies Ltd. offers drug discovery services. It combines world-renowned expertise in synthetic chemistry and molecular pharmacology to produce fluorescent reagents as tracers for G-protein coupled receptors (GPCRs) and other common drug discovery target classes. The company was founded by Barrie Kellam, Stephen J. Hill and George Michael in 2003 and is headquartered in Nottingham, the United Kingdom. | Chief Executive Officer | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
CellAura Technologies Ltd.
![]() CellAura Technologies Ltd. Pharmaceuticals: MajorHealth Technology CellAura Technologies Ltd. offers drug discovery services. It combines world-renowned expertise in synthetic chemistry and molecular pharmacology to produce fluorescent reagents as tracers for G-protein coupled receptors (GPCRs) and other common drug discovery target classes. The company was founded by Barrie Kellam, Stephen J. Hill and George Michael in 2003 and is headquartered in Nottingham, the United Kingdom. | Health Technology |
Q-Flo Ltd.
![]() Q-Flo Ltd. Miscellaneous Commercial ServicesCommercial Services Q-Flo Ltd. provides research in the areas of advanced nano-enabled materials. It produces long carbon nanotube fibre and mats is patent protected and operates as a single stage continuous process. The company was founded by Alan Windle and Martin Pick in 2004 and is headquartered in Nottingham, the United Kingdom. | Commercial Services |
Micropore Technologies Ltd.
![]() Micropore Technologies Ltd. BiotechnologyHealth Technology Micropore Technologies Ltd. develops and manufactures membrane emulsification technologies and chemicals. The firm offers entry level dispersion cells, laboratory scale torsional systems, laboratory scale crossflow systems, pilot and production scale torsional systems, and pilot and production scale crossflow systems; and consultancy services. Its products are used in pharmaceuticals, food and beverages, chromatography, inks, nutraceuticals, specialist particles and emulsions, agrochemical, veterinarian and animal feed, and insect repellents, as well as cosmetics, fragrances, and skincare applications. The company was founded by Richard Holdich in 2003 and is headquartered in Redcar, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- David Christopher Hayward